CytoTerra offers a genome proximity mapping platform that enables researchers to visualize and analyze the three‑dimensional organization of DNA within cells. The service uses proprietary CytoTerra® technology to generate high‑resolution spatial maps, helping scientists link genomic architecture to functional outcomes such as gene regulation and disease mechanisms.
Funding
Funding not disclosed
Founders
Product
Problem
Understanding how DNA sequences interact within the three‑dimensional space of the nucleus is difficult with conventional sequencing methods, which lose spatial context and limit insight into regulatory mechanisms.
Solution
CytoTerra offers a genomic analysis platform that maps the spatial relationships of DNA sequences inside cells using its proprietary Genome Proximity Mapping® technology. The system generates high‑resolution, three‑dimensional chromatin architecture maps that can be integrated into existing sequencing workflows. These maps enable researchers to identify gene‑regulatory interactions, assess chromatin looping, and explore structural variations in their native cellular context. By providing detailed spatial data, the platform supports functional genomics studies, drug target discovery, and precision‑medicine applications.
Target Audience
Primary users are academic and industry researchers in genomics, molecular biology, and pharmaceutical development who require spatial genomic insights for target validation and precision‑medicine studies.
Features
- Genome Proximity Mapping® technology delivering high‑resolution 3D chromatin maps
- Compatibility with standard sequencing pipelines for seamless data integration
- Visualization tools for interactive exploration of spatial gene interactions
- Analytical modules for identifying regulatory loops and structural variants
- Scalable workflow suitable for large‑scale drug discovery and functional genomics projects